Sickle Cell Crisis

Sickle Cell Crisis occurs when the red blood cells change their shape causing cells not to get oxygen. The company estimates that the annual incidence for this indication in the United States and Europe is about 260,000 cases.

OXYCYTE may help in treating this due to it’s ability to enhance the oxygen carrying capacity of the bloodstream.

The company plans to submit a clinical trial protocol for this indication to the FDA during 2010. This page will be updated as the company releases new information.